Why is Titan Biotech falling/rising?

As of 25-Jul, Titan Biotech Ltd's stock price is currently at 446.00, reflecting a decrease of 2.6, or 0.58%. The stock has been experiencing a downward trend, having fallen for the last two consecutive days, with a total decline of 1.1% during this period. Today's performance indicates that the stock has outperformed its sector by 0.72%, despite touching an intraday low of Rs 435.7. Over the past week, the stock has decreased by 2.62%, while it has shown a more favorable performance of 10.56% over the past month. However, the company has reported negative results for the last three consecutive quarters, with significant declines in profit before tax and profit after tax, contributing to a perception of poor long-term growth. Additionally, the stock is trading at a premium compared to its peers, which may deter potential investors.
In the broader market context, the Sensex has experienced a minor decline of 0.36% over the past week, indicating that while Titan Biotech's short-term performance is worse than the benchmark, it has outperformed the market over the past month. However, the stock has underperformed significantly over the past year, with a return of -23.16% compared to the Sensex's positive return of 1.78%. This underperformance, coupled with a high price-to-book value ratio and declining profits, suggests that investor sentiment may be cautious, impacting the stock's price negatively.